CD36 localization on the plasma membranes of hepatocytes was markedly increased in patients with NASH as compared to people with normal livers or simple hepatic steatosis, in which CD36 palmitoylation plays a key role via increased CD36 protein hydrophobicity [56]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.